Author: Jane Edwards|| Date Published: December 28, 2016
Four companies have won spots on a potential 10-year, $159 million contract to provide preclinical drug development support services for the National Institute of Allergy and Infectious Diseases.
The multiple-award, indefinite-delivery/indefinite-quantity contract covers the development of manufacturing processes and analytical test procedures, regulatory services, manufacturing and product characterization in support of the development of biopharmaceutical drug candidates for infectious diseases, the National Institutes of Health said in a FedBizOpps notice.
Government IT services contractor Aretum has promoted Amy French, most recently chief accounting officer, to chief financial officer. Vienna, Virginia-based…
Shield AI has agreed to acquire simulation software company Aechelon Technology as part of efforts to expand its technological capabilities. The San Diego-based…
SentinelOne, a company specializing in artificial intelligence security, has promoted Barry Padgett to president and chief operating officer. The appointment takes effect…
Anduril Industries and Palantir Technologies are helping develop software for the potential $185 billion Golden Dome next-generation missile defense shield,…
Four companies have won spots on a potential 10-year, $159 million contract to provide preclinical drug development support services for the National Institute of Allergy and Infectious Diseases.
